INTERNATIONAL PATENT: REGENERON PHARMACEUTICALS, INC. FILES APPLICATION FOR "TREATMENT OF PARKINSON'S DISEASE WITH SIM BHLH TRANSCRIPTION FACTOR 2 (SIM2) AGONISTS"

GENEVA, Feb. 4 -- REGENERON PHARMACEUTICALS, INC. (777 Old Saw Mill River RoadTarrytown, New York 10591) filed a patent application (PCT/US2025/039225) for "TREATMENT OF PARKINSON'S DISEASE WITH SIM BHLH TRANSCRIPTION FACTOR 2 (SIM2) AGONISTS" on Jul 25, 2025. With publication no. WO/2026/025015, the details related to the patent application was published on Jan 29, 2026.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): GELFMAN, Sahar (777 Old Saw Mill River RoadTarrytown, New York 10591), AIME-WILSON, Pascaline (777 Old Saw Mill River RoadTarrytown, New York 10591), STAHL, Eli (777 Old Saw Mill Ri...